Cancer antigen 125 ca 125 antigen. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy21

Peritoneum T-Lymphocytes Cell Line Cell Line, Tumor Tumor Cells, Cultured Immune Sera B-Lymphocytes Cells, Cultured Spleen Dendritic Cells T-Lymphocytes, Cytotoxic Lymphocytes Antigen-Presenting Cells Lymph Nodes CD8-Positive T-Lymphocytes CD4-Positive T-Lymphocytes Cell Membrane Clone Cells Hybridomas CA1 Region, Hippocampal Prostate

Organisms7

Mice, Inbred BALB C Mice, Inbred C57BL Mice, Nude Rabbits Simian virus 40 Mice, Transgenic Mice, Inbred Strains

Diseases27

Ovarian Neoplasms Prostatic Neoplasms Krukenberg Tumor Neoplasms Breast Neoplasms Lung Neoplasms Neoplasm Metastasis Adenocarcinoma Colonic Neoplasms Stomach Neoplasms Pancreatic Neoplasms Neoplasm Invasiveness Uterine Cervical Neoplasms Disease Progression Genetic Predisposition to Disease Cell Transformation, Neoplastic Carcinoma, Squamous Cell Colorectal Neoplasms Melanoma Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Rectal Neoplasms Carcinoma Neoplasm Recurrence, Local Hypersensitivity, Delayed Disease Models, Animal Liver Neoplasms

Chemicals and Drugs116

CA-125 Antigen Antigens, Neoplasm Antigens Antigens, Bacterial Antigens, Surface Antigens, Tumor-Associated, Carbohydrate Carcinoembryonic Antigen Antigens, Viral Mucin-1 Tumor Markers, Biological Antibodies, Monoclonal Antigens, Protozoan CA-19-9 Antigen Antigens, Polyomavirus Transforming Cancer Vaccines HLA Antigens Dialysis Solutions Antigens, CD Antigens, Fungal Antigens, Helminth H-2 Antigens Epitopes Prostate-Specific Antigen Antigens, Viral, Tumor Antibodies, Neoplasm Receptors, Antigen, T-Cell HLA-DR Antigens Proliferating Cell Nuclear Antigen Neoplasm Proteins Histocompatibility Antigens Histocompatibility Antigens Class II Receptors, Antigen, B-Cell O Antigens Antigens, CD15 HLA-A2 Antigen GPI-Linked Proteins Antigens, CD8 RNA, Messenger Immunoglobulin G Antigens, CD3 Blood Group Antigens Hepatitis B Surface Antigens HLA-A Antigens Membrane Proteins Histocompatibility Antigens Class I Receptors, Antigen HLA-D Antigens Antigens, CD45 Hepatitis B Antigens Antigens, CD4 Antigens, CD1 Immune Sera Antibodies, Bacterial Antigens, Differentiation HLA-B Antigens MART-1 Antigen Antigens, CD80 Antibodies HIV Antigens Recombinant Proteins Epstein-Barr Virus Nuclear Antigens Antigens, CD19 Ki-67 Antigen Antigens, Heterophile Autoantigens Antigens, CD40 Hepatitis B Core Antigens Antigen-Antibody Complex Immunoglobulin M Antigens, Thy-1 Forssman Antigen Peptides H-Y Antigen Interferon-gamma Ovalbumin Antigens, CD86 HLA-DQ Antigens Antineoplastic Agents Antibodies, Viral CTLA-4 Antigen Receptors, Antigen, T-Cell, alpha-beta Ca(2+) Mg(2+)-ATPase Lewis Blood-Group System Membrane Glycoproteins Glycoproteins Antigens, CD95 Antigens, CD79 Antibodies, Protozoan gp100 Melanoma Antigen Autoantibodies Antigens, Nuclear Calcium Recombinant Fusion Proteins Antigens, CD2 Antibodies, Helminth Receptors, Estrogen Antigens, T-Independent Antigens, CD28 Hepatitis B e Antigens DNA, Neoplasm Tumor Suppressor Protein p53 Minor Histocompatibility Antigens ABO Blood-Group System HLA-A24 Antigen HLA-B27 Antigen HLA-C Antigens RNA, Small Interfering Antigens, CD24 Hepatitis delta Antigens Peptide Fragments Nuclear Proteins Antigens, CD44 Antigens, CD58 DNA Primers Adjuvants, Immunologic Antigens, CD1d

Analytical, Diagnostic and Therapeutic Techniques and Equipment46

Enzyme-Linked Immunosorbent Assay Sensitivity and Specificity Immunoenzyme Techniques Early Detection of Cancer Prognosis Neoplasm Staging Immunohistochemistry Fluorescent Antibody Technique Lymphocyte Activation Immunotherapy Peritoneal Dialysis Prospective Studies ROC Curve Blotting, Western Flow Cytometry Immunization Peritoneal Dialysis, Continuous Ambulatory Reverse Transcriptase Polymerase Chain Reaction Transfection Polymerase Chain Reaction Immunodiffusion Survival Analysis Neoplasm Transplantation Survival Rate Complement Fixation Tests Immunoblotting Retrospective Studies Electrophoresis, Polyacrylamide Gel Gene Expression Profiling Follow-Up Studies Immunoelectrophoresis Antineoplastic Combined Chemotherapy Protocols Immunoassay Risk Serologic Tests Hemagglutination Tests Xenograft Model Antitumor Assays Cloning, Molecular Transplantation, Heterologous Disease Models, Animal Models, Biological Registries Risk Assessment Disease-Free Survival Combined Modality Therapy Radioimmunoassay

Phenomena and Processes37

Sensitivity and Specificity Amino Acid Sequence Cross Reactions Antibody Specificity Lymphocyte Activation Base Sequence Antigen-Antibody Reactions Antibody Formation Mutation Gene Expression Regulation, Neoplastic Time Factors Molecular Weight Cell Division Transfection Genetic Predisposition to Disease Immunity, Cellular Phenotype Signal Transduction Dose-Response Relationship, Drug Gene Expression Protein Binding Cytotoxicity, Immunologic Drug Resistance, Neoplasm Cell Proliferation Risk Immune Tolerance Cell Survival Down-Regulation Genotype Apoptosis Cell Movement Phosphorylation Cell Differentiation Promoter Regions, Genetic Major Histocompatibility Complex Genetic Vectors Up-Regulation

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena1

National Cancer Institute (U.S.)

Information Science5

Molecular Sequence Data Amino Acid Sequence Base Sequence Survival Rate Registries

Health Care15

Sensitivity and Specificity Prospective Studies ROC Curve Immunization Peritoneal Dialysis, Continuous Ambulatory Survival Analysis Survival Rate Retrospective Studies Follow-Up Studies Risk National Cancer Institute (U.S.)Age Factors Registries Risk Assessment Disease-Free Survival

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Health Care

CA-125 Antigen Antigens, Neoplasm Antigens Antigens, Bacterial Antigens, Surface Antigens, Tumor-Associated, Carbohydrate Carcinoembryonic Antigen Antigens, Viral Ovarian Neoplasms Mucin-1 Tumor Markers, Biological Antibodies, Monoclonal Antigens, Protozoan CA-19-9 Antigen Antigens, Polyomavirus Transforming Cancer Vaccines HLA Antigens Prostatic Neoplasms Dialysis Solutions Antigens, CD Antigens, Fungal Enzyme-Linked Immunosorbent Assay Antigens, Helminth H-2 Antigens Peritoneum Epitopes Krukenberg Tumor Prostate-Specific Antigen Neoplasms Antigens, Viral, Tumor Molecular Sequence Data Breast Neoplasms Sensitivity and Specificity Immunoenzyme Techniques Antibodies, Neoplasm Receptors, Antigen, T-Cell HLA-DR Antigens Lung Neoplasms Proliferating Cell Nuclear Antigen Neoplasm Metastasis Neoplasm Proteins Histocompatibility Antigens Amino Acid Sequence Histocompatibility Antigens Class II Early Detection of Cancer Receptors, Antigen, B-Cell O Antigens Prognosis T-Lymphocytes Antigens, CD15 Mice, Inbred BALB C HLA-A2 Antigen GPI-Linked Proteins Antigens, CD8 Adenocarcinoma RNA, Messenger Neoplasm Staging Immunohistochemistry Immunoglobulin G Cell Line Antigens, CD3 Cell Line, Tumor Tumor Cells, Cultured Blood Group Antigens Cross Reactions Hepatitis B Surface Antigens HLA-A Antigens Membrane Proteins Histocompatibility Antigens Class I Fluorescent Antibody Technique Antibody Specificity Lymphocyte Activation Colonic Neoplasms Immunotherapy Peritoneal Dialysis Prospective Studies ROC Curve Receptors, Antigen HLA-D Antigens Antigens, CD45 Hepatitis B Antigens Antigens, CD4 Base Sequence Antigen-Antibody Reactions Antigens, CD1 Antibody Formation Immune Sera Antibodies, Bacterial Stomach Neoplasms Blotting, Western Mice, Inbred C57BL Flow Cytometry Antigens, Differentiation HLA-B Antigens Immunization Mice, Nude B-Lymphocytes Peritoneal Dialysis, Continuous Ambulatory Cells, Cultured Mutation

No FAQ available that match "cancer antigen 125 ca 125 antigen"